Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | 1123 일 전
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

read more
Swiss Market Settles Marginally Up

Swiss Market Settles Marginally Up

The Switzerland market ended marginally up on Monday, despite struggling a bit early on in the session, and then for a few minutes in the final hour.
RTTNews | 2 시간 53 분 전
European Stocks Close Mostly Lower After Cautious Session

European Stocks Close Mostly Lower After Cautious Session

European stocks closed mostly weak on Monday amid geopolitical tensions, and the Trump administration's announcement of sweeping changes to the H-1B visa regime. Profit warnings by a few major auto companies weighed as well.
RTTNews | 3 시간 19 분 전
TSX Hits New High, Up Nearly 0.5%; Materials Stocks Rally Again

TSX Hits New High, Up Nearly 0.5%; Materials Stocks Rally Again

After moving to a new record high thanks to strong buying in the materials sector, the Canadian market remains fairly well placed in positive territory a little past noon on Monday. Amid geopolitical tensions and rising bets on more monetary easing by the Federal Reserve this year, gold and silver prices have risen sharply today, triggering hectic buying in the materials sector.
RTTNews | 4 시간 30 분 전
Kirkland Signature Ahi Tuna Wasabi Poke Sold At Costco Recalled

Kirkland Signature Ahi Tuna Wasabi Poke Sold At Costco Recalled

Western United Fish Co., dba Annasea Foods Group, is recalling around 3,300 pounds of Kirkland Signature Ahi Tuna Wasabi Poke sold at Costco stores due to potential contamination with Listeria monocytogenes, according to the U.S. Food and Drug Administration.
RTTNews | 8 시간 20 분 전
FTSE 100 Up Marginally; Miners In Demand

FTSE 100 Up Marginally; Miners In Demand

The U.K. stock market is somewhat subdued on Monday with investors mostly staying cautious, looking ahead to reports on manufacturing and services sector activity from major economies for directional clues. A key reading on U.S. inflation is also due this week.
RTTNews | 9 시간 17 분 전
CAC 40 Modestly Lower In Cautious Trade

CAC 40 Modestly Lower In Cautious Trade

French stocks are modestly lower on Monday with investors making cautious moves, looking ahead to the data on manufacturing and services sector activity in major European economies, and a key U.S. inflation reading this week.
RTTNews | 9 시간 50 분 전